CN110438055B - Whole-cell catalyst containing phenylpyruvate decarboxylase mutant and application of whole-cell catalyst in production of phenethyl alcohol - Google Patents

Whole-cell catalyst containing phenylpyruvate decarboxylase mutant and application of whole-cell catalyst in production of phenethyl alcohol Download PDF

Info

Publication number
CN110438055B
CN110438055B CN201910705699.4A CN201910705699A CN110438055B CN 110438055 B CN110438055 B CN 110438055B CN 201910705699 A CN201910705699 A CN 201910705699A CN 110438055 B CN110438055 B CN 110438055B
Authority
CN
China
Prior art keywords
whole
leu
yqdh
glu
cell catalyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910705699.4A
Other languages
Chinese (zh)
Other versions
CN110438055A (en
Inventor
陈守文
占杨杨
王欢
石姣
周梦林
马昕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei University
Original Assignee
Hubei University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei University filed Critical Hubei University
Priority to CN201910705699.4A priority Critical patent/CN110438055B/en
Publication of CN110438055A publication Critical patent/CN110438055A/en
Application granted granted Critical
Publication of CN110438055B publication Critical patent/CN110438055B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/01Carboxy-lyases (4.1.1)
    • C12Y401/01043Phenylpyruvate decarboxylase (4.1.1.43)

Abstract

The invention belongs to the technical field of bioengineering, and particularly relates to a whole-cell catalyst containing a phenylpyruvate decarboxylase mutant and application of the whole-cell catalyst in production of phenethyl alcohol. The invention uses phenylethanol tolerant bacteria bacillus licheniformis as an expression host, heterologously expresses a phenylpyruvate decarboxylase mutant from lactococcus lactis and alcohol dehydrogenase from the bacillus licheniformis through a free plasmid pHY300PLK, and obtains the recombinant bacillus licheniformis co-expressed by the phenylpyruvate decarboxylase and the alcohol dehydrogenase. And (3) producing the phenethyl alcohol by whole-cell catalysis of the recombinant bacteria by using the L-phenylalanine as a substrate. Has the advantages of low production cost, mild production conditions, less impurities in a conversion system, simple process steps, safe production operation and the like.

Description

Whole-cell catalyst containing phenylpyruvate decarboxylase mutant and application of whole-cell catalyst in production of phenethyl alcohol
Technical Field
The invention belongs to the technical field of bioengineering, and particularly relates to a whole-cell catalyst containing a phenylpyruvate decarboxylase mutant and application of the whole-cell catalyst in production of phenethyl alcohol.
Background
Phenethyl alcohol is an aromatic alcohol with elegant, fine and persistent rose fragrance. Due to its peculiar smell, phenethyl alcohol is widely used as a fragrance substance in perfumes, cosmetics and food industries. The phenethyl alcohol can also be used as an insecticide and a novel biofuel. Therefore, the phenethyl alcohol has wide application prospect.
Currently, the synthesis of phenethyl alcohol mainly comprises a chemical method and a biological method, and the biological method is divided into an extraction method and a fermentation method. In the process of phenethyl alcohol biosynthesis, phenylalanine generates phenylpyruvic acid through transamination, the phenylpyruvic acid is further decarboxylated into phenylacetaldehyde, and the phenylacetaldehyde is further reduced into phenethyl alcohol, and the process needs the participation of coenzyme NADH or NADPH. Whole cell transformation has the following advantages over the isolated enzyme: the whole-cell biocatalyst is easier to prepare and has low cost; compared with the separating enzyme, the separating enzyme is more stable, is not easily influenced by factors such as environmental temperature, pH and the like, and is convenient to use; no toxic and harmful products and no other by-products are produced in the conversion process. Is expected to realize the industrialized production of the phenethyl alcohol with low energy consumption, high efficiency, high purity and no pollution.
Heretofore, studies have been made on co-expression of three enzymes (phenylalanine transaminase, keto-acid decarboxylase and alcohol dehydrogenase) in yeast and E.coli and production of phenethyl alcohol by whole-cell transformation, but the methods have the following disadvantages: (1) escherichia coli is not a food-grade microorganism, and endotoxin generated in the fermentation process of Escherichia coli can bring about a new food safety problem; (2) the operation process of taking the escherichia coli as the whole-cell catalyst is complex, an inducer needs to be added in the culture process, and strict induction conditions are controlled; (3) the tolerance of the yeast and the escherichia coli to the phenethyl alcohol is low, and the high yield of the phenethyl alcohol is not facilitated; (3) the whole cell catalyst of the yeast is cultured for too long time, and the whole process is as long as 100 hours.
Ketoacid decarboxylase KivD from lactococcus lactis is a ketoacid decarboxylase with a wide substrate spectrum and can catalyze branched ketoacids, 3-methyl-2-oxobutanoic acid, 4-methyl-2-oxovaleric acid and 3-methyl-2-oxovaleric acid, aromatic ketoacids, 4-hydroxyphenylpyruvate, phenylpyruvic acid and benzoylformic acid, and linear ketoacid 2-oxohexanoic acid, 2-oxopentanoic acid and pyruvic acid at the same time. The KivD best suited substrate for the production of isobutanol was found by enzymatic profiling to be 3-methyl-2-oxobutanoic acid in branched-chain keto acids. Lactococcus lactis has been analyzed for protein structure, and researchers found that valine at position 461, serine at position 268, phenylalanine at position 381, and methionine at position 538 near the catalytic active center play important roles in substrate catalysis. The 4 amino acids become key targets for obtaining the corresponding products. Researchers Peter Lindblad et al constructed V461I (VI), V461L (VL), V461F (VF), V461A (VA), M538W (MW), S286T (ST), S286Y (SY), S286A (SA), F542L (FL) and F542W (FW) mutants by making a series of mutations at these four sites in order to increase the yield of isobutanol and increase the catalytic activity of KivD on 3-methyl-2-oxobutanoic acid. Among a plurality of mutants, only the isobutanol yield of ST and VI is greatly improved, and the catalytic activity of 3-methyl-2-oxobutanoic acid is improved. The James C.Liao subject group carries out double-site overlapping mutation on KivD to improve the synthesis of 3-methyl-1-pentanol, and the construction is strain mutant strains which are respectively V461A/M538A, V461A/M538L, V461A/F381A and V461A/F381L, wherein the yield of the 3-methyl-1-pentanol in the four mutants is improved by 20-50 times compared with that of a control strain, and the yield of the 3-methyl-1-pentanol in V461A/F381L is the highest and reaches 384.3 +/-30.3 mg/L. KivD was hardly used for the synthesis of phenethyl alcohol due to its low substrate affinity and catalytic efficiency for phenylpyruvic acid.
Disclosure of Invention
The invention provides a whole-cell catalyst containing a phenylpyruvic acid decarboxylase mutant for solving the defects in the prior art, and the whole-cell catalyst is a recombinant bacillus licheniformis containing the phenylpyruvic acid decarboxylase mutant and alcohol dehydrogenase.
The invention also aims to provide application of the whole-cell catalyst containing the phenylpyruvate decarboxylase mutant, and the cell catalyst can be used for preparing the phenethyl alcohol or the phenethyl alcohol derivative by directly using the L-phenylalanine as a substrate.
In order to achieve the purpose, the invention adopts the following technical measures:
a whole-cell catalyst containing a phenylpyruvate decarboxylase mutant is a bacillus licheniformis co-expressing the phenylpyruvate decarboxylase mutant F542W and alcohol dehydrogenase, and the amino acid sequence of the mutant F542W is shown in SEQ ID NO. 1.
In the above scheme, preferably, the Bacillus licheniformis is Bacillus licheniformis DW2, CC TCC NO: m2011344;
in the above-mentioned embodiment, preferably, the alcohol dehydrogenase is derived from Bacillus licheniformis DW2, and the amino acid sequence of the alcohol dehydrogenase is shown in SEQ ID NO. 2.
In the above-mentioned scheme, specifically, the gene encoding the mutant F542W and the alcohol dehydrogenase encoding gene yqdH derived from Bacillus licheniformis DW2 were constructed into the plasmid pHY300PLK, and then transformed into Bacillus licheniformis DW 2.
The application of the whole-cell catalyst containing the phenylpyruvate decarboxylase mutant comprises the steps of preparing phenethyl alcohol or phenethyl alcohol derivatives by using the whole-cell catalyst provided by the invention;
in the above-mentioned application, preferably, the fermentation system comprises: 40-120g/L of molasses, 1-10g/L of L-phenylalanine, 0.5-5g/L of yeast extract and KH2PO40.5-20g/L,K2HPO40.5-10g/L, 2-10g/L sodium citrate and MgSO4·7H2O0.1-1.0g/L,MnCl20.001-0.01g/L,CaCl20.001-0.005g/L and FeSO4·7H2O0.001-0.005g/L,pH 6.5~7.5。
Compared with the prior art, the invention has the following advantages:
1) according to the invention, the 542 th phenylalanine near the catalytic domain of the phenylpyruvate decarboxylase molecule is mutated into the tryptophan (named as mutant F542W) in a site-specific mutation mode, so that the enzyme activity of the phenylpyruvate decarboxylase is obviously improved, and the problem of low catalytic efficiency of the conventional phenylpyruvate decarboxylase on the phenylpyruvate is solved.
2) The invention can obviously improve the catalytic efficiency of converting phenylalanine into phenethyl alcohol and improve the conversion rate of phenylpyruvic acid by coexpressing mutated ketonic acid decarboxylase and bacillus licheniformis self alcohol dehydrogenase.
Drawings
FIG. 1 shows SDS-PAGE electrophoresis of YqdH-induced expression and purification of alcohol dehydrogenase;
wherein lane M: marker; 1-3: the purified Ni-NTA gave pure YqdH protein, lanes 4-6 were binding solution, 20mM imidazole washing solution, 50mM imidazole washing solution, and lane 7 was the supernatant after cell disruption, respectively.
FIG. 2 plasmid map of recombinant plasmid pHY-kivD-yqdH construction.
Detailed Description
The following examples are further illustrative of the present invention and are not intended to be limiting thereof. The technical scheme of the invention is a conventional scheme in the field if not specifically stated; the reagents or materials, if not specifically mentioned, are commercially available.
Seed culture medium: 10g/L of peptone, 5g/L of yeast powder and 10g/L of NaCl.
And (3) determination of phenethyl alcohol: the content of the phenethyl alcohol is analyzed by adopting gas chromatography, and the specific method comprises the following steps: centrifuging the fermentation liquor at 12000rpm for 10min to obtain 400 μ L of fermentation supernatant; adding 1.2mL ethyl acetate containing 1g/L internal standard for extraction, oscillating and mixing uniformly for 5min, and centrifuging at 10000rpm for 2 min; taking 800 μ L of the supernatant, adding 0.2g of anhydrous sodium sulfate, mixing, and standing at room temperature for 30 min; centrifuging to obtain supernatant, and measuring the concentration of the fermentation product by gas chromatography. The fermentation product is measured by Agilent 7890B gas chromatograph (equipped with FID detector), the sample volume is 1 μ L, no shunt sample injection is carried out, and the carrier gas is hydrogen (1 ml/min). The column temperature procedure was: equilibrating at 50 deg.C for 2min, heating to 160 deg.C at 10 deg.C/min, heating to 220 deg.C at 20 deg.C/min, and holding for 3 min.
Example 1:
1) construction of recombinant plasmid pHY-kivD:
an alpha-keto acid decarboxylase kivD gene was cloned from Lactococcus lactis subsp.lactis, CICC6246 using kivD-F and kivD-R. Amplifying by taking Bacillus subtilis 168 genome as a template and P43-F and P43-R as primers to obtain a P43 promoter; and taking TamyL-F and TamyL-R as primers for amplification to obtain an amylase terminator TamyL. P43-F and TamyL-R are used as primers to carry out SOE-PCR on three fragments of P43, kivD and TamyL to obtain a fusion fragment P43-kivD-TamyL. Plasmid pHY300PLK is used as a template, pHY-T5-F and pHY-T5-R are used as primers to carry out whole plasmid PCR amplification, and a linearized pHY300PLK vector is obtained. And (3) after the amplification products are subjected to electrophoresis detection, purifying and recovering the PCR products by using a gel recovery kit. The fusion fragment was fused with the linearized vector pHY300PLK by the Clonexpress II one-step cloning kit to obtain the recombinant plasmid pHY-kivD.
P43-F:TTTTTATAACAGGAATTCTGATAGGTGGTATGTTTTCG
P43-R:TAATCTCCTACTGTATACATTGATCCTTCCTCCTTTAGA
kivD-F:CTAAAGGAGGAAGGATCAATGTATACAGTAGGAGATTA
kivD-R:TCCGTCCTCTCTGCTCTTTTATGATTTATTTTGTTCAG
TamyL-F:CTGAACAAAATAAATCATAAAAGAGCAGAGAGGACGGATT
TamyL-R:AAGCTTCTAGAAGCTTCTAGCGCAATAATGCCGTCGCACT
pHY-T5-F:GAATTCCTGTTATAAAAAAAGGATC
pHY-T5-R:TCTAGAAGCTTGGGCAAAGCGTTTT;
The fused recombinant plasmid pHY-kivD was transformed into competent E.coli DH 5. alpha. and positive colonies were screened with ampicillin-containing LB plates. After overnight shake culture at 37 ℃ the plasmid pHY-kivD was extracted and verified by sequencing.
2) Enzyme activity assay of wild KivD:
the correct plasmid pHY-kivD will be sequenced and transformed into Bacillus licheniformis DW 2. Selecting transformants, verifying the transformants to be correct, inoculating the transformants into an LB culture medium, and culturing for 14h at 37 ℃; the cells were transferred to a fermentation medium with an inoculum size of 3%, cultured at 37 ℃ for 24 hours, harvested by centrifugation, washed twice with PBS, and finally resuspended in 1 ml of 50mM potassium phosphate buffer (pH 6.8). Cell disruption was performed using an ultrasonograph, which was set up: 150W, 20kHz, 2s of work; closing for 2s, taking 8 minutes totally, centrifuging at 4 ℃ and collecting supernatant fluid to obtain crude enzyme liquid.
The supernatant was subjected to enzyme activity assay according to the following system, enzymatic reaction system (200. mu.L): 50mM potassium phosphate buffer (pH 6.8), 1mM magnesium sulfate heptahydrate, 0.5mM thiamine pyrophosphate, 5mM sodium propiophenonate and 10. mu.L of the crude enzyme solution were reacted at 30 ℃. Measuring the absorbance at 320nm by using a microplate reader to measure the activity of the phenylpyruvate decarboxylase, and defining the enzyme quantity required by consuming 1 micromole of the substrate phenylpyruvate per minute as one enzyme activity unit (U). The enzyme activity measurement result shows that the enzyme activity (enzyme concentration) of the wild KivD is 290.05U/mL.
3) Preparation of expression plasmid pHY-F542W for pyruvate decarboxylase mutant:
the constructed pHY-kivD is used as a template, a primer is designed to carry out whole plasmid PCR amplification, and a pHY300PLK vector of a linearized P43 promoter and an amylase TamyL terminator is obtained. Site-directed mutagenesis is carried out on the kivD catalytic active site, and the mutation is replaced to a gene sequence in a primer mode, specifically comprising the following steps:
the 542 th phenylalanine is mutated into tryptophan, the base TGG of the 542 th amino acid of the coded kivD is split into two parts, primers F542W-AR and F542W-BF, and the upper section and the lower section of a kivD mutant sequence are amplified by taking pHY-kivD plasmid as a template; two sections were subjected to SOE-PCR using kivD-F and kivD-R as primers to amplify the kivD mutant sequence F542W.
And purifying and recovering the PCR product by using a gel recovery kit, and carrying out electrophoresis detection on the recovered product. Fusing the fused mutant fragment with a linearized vector pHY300PLK with a P43 promoter and an amylase TamyL terminator, converting a product into E.coli DH5 alpha, and obtaining a recombinant plasmid pHY-F542W, wherein the amino acid sequence of the expressed mutant F542W is shown in SEQ ID No. 1;
F542W-AR:GATTTATTTTGTTCAGCCCATAGTTTGCCCATTTTTTTC
F542W-BF:GAAAAAAATGGGCAAACTATGGGCTGAACAAAATAAATC。
4) enzyme activity assay of mutant F542W
Transforming the mutant plasmid of the step 3) into Bacillus licheniformis DW 2. Selecting transformants, verifying the transformants to be correct, inoculating the transformants into an LB culture medium, and culturing for 14h at 37 ℃; transferring the strain into a fermentation medium, wherein the inoculation amount is 3%, culturing at 37 ℃ for 24h, detecting the enzyme activity of the mutant according to the method in the step 2), and the enzyme activity (enzyme concentration) of the mutant F542W is 1195.18U/mL.
Example 2:
1) cloning of Bacillus licheniformis DW2 alcohol dehydrogenase encoding Gene yqdH
Sequence alignment was performed in NCBI database based on the amino acid sequence of Bacillus licheniformis alcohol dehydrogenase YqdH, and it was found to have 38.65% homology with alcohol dehydrogenase YqhD of E.coli K12. YqhD is reported to have a broad substrate spectrum. To test the catalytic ability of Bacillus licheniformis YqdH to phenylacetaldehyde, primers yqdH-F1 and yqdH-R1 were designed based on the gene sequence of yqdH, and the yqdH sequence was amplified using the genomic DNA of Bacillus licheniformis as a template. And carrying out enzyme digestion on the yqdH fragment of the alcohol dehydrogenase gene by using Ba mHI and XhoI, connecting the fragment with an expression vector pET28a (+) subjected to the same enzyme digestion by using T4DNA ligase, transforming E.coli DH5 alpha competent cells by using a connecting product, transferring the transformed positive clone into a liquid LB culture medium for overnight culture, and extracting to obtain a recombinant expression plasmid pET28 a-yqdH. The recombinant expression plasmid pET28a-yqdH is transformed into E.coli BL21(DE3) competent cells, and positive clones are screened on a resistant culture medium to obtain a recombinant strain BL21(DE3)/pET28 a-yqdH.
yqdH-F1:CGGGATCCATGGATAATTTTACATATTG
yqdH-R1:CCGCTCGAGTTATAAAGAAGCCTTCAAAAT
2) Inducible expression and purification of YqdH protein
The BL21(DE3) strain containing the recombinant plasmid pET28a-yqdH was inoculated into 100mL of LB liquid medium, cultured with shaking at 37 ℃ and 230rpm for 3 hours, and after OD600 reached about 0.8, the final concentration of 0.5mM IPTG was added, and induced at 37 ℃ and 230rpm for 4 hours. And centrifuging the induced culture medium to collect thalli, resuspending the thalli by using a proper amount of phosphate buffer solution with the pH value of 8.0, crushing the thalli by using a low-temperature high-pressure cell crusher, centrifuging to remove cell fragments, detecting the expression of the alcohol dehydrogenase YqdH by using SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) of the obtained soluble total protein solution, wherein the protein electrophoresis result shows that an obvious band can be seen at the position of about 42.5kDa (figure 1), and the expression of the alcohol dehydrogenase YqdH in escherichia coli is shown.
E.coli BL21(DE3)/pET28a-yqdH fermentation broth after IPTG induction is centrifuged at 12000rpm for 5min, and thalli are collected; the cells were resuspended in an appropriate amount of solution I (20mM Tris-HCl (pH 7.9), 10mM imidazole, 0.5M NaCl; and disrupted by a low-temperature high-pressure cell disrupter); centrifuging at 12000rpm at 4 deg.C for 20min, and collecting supernatant to obtain crude enzyme solution; taking 20mL of crude enzyme solution, loading the crude enzyme solution on a Ni-NTA affinity chromatography column, and collecting a penetration peak; the column was washed with 15 column volumes of solution II (20mM Tris-HCl (pH 7.9), 20mM imidazole, 0.5M NaCl;) to remove the contaminating proteins; eluting YqdH protein with appropriate amount of solution III (20mM Tris-HCl (pH 7.9), 500mM imidazole, 0.5M NaCl;) and collecting the eluate; the protein purity in the eluate was checked by SDS-PAGE and desalted. The protein electrophoresis result shows that the YqdH protein accounts for more than 90 percent, the high-purity purified protein (figure 1) is obtained, and the amino acid sequence of the expressed alcohol dehydrogenase is shown as SEQ ID NO. 2.
3) Enzyme activity determination of recombinant alcohol dehydrogenase YqdH
The purified protein was subjected to enzyme activity measurement according to the following system, enzymatic reaction system (200. mu.L): containing 50mM MOPS buffer (pH7.0), 5mM phenylacetaldehyde, 0.2mM NADH, and 10. mu.L of purified alcohol dehydrogenase enzyme solution, reacting at 30 ℃, measuring absorbance at 340nm every 1min by an enzyme-labeling instrument, and continuously measuring for 20 min. 1 enzyme activity unit (U) is defined as the amount of enzyme required to consume 1 nNADH per minute under the given conditions. The result of enzyme activity measurement is that the specific enzyme activity of the alcohol dehydrogenase is 10.39U/mg. The YqdH in the source bacillus licheniformis can catalyze phenylacetaldehyde to synthesize phenethyl alcohol.
Example 3:
construction of the Co-expression recombinant plasmid pHY-F542W-yqdH:
the yqdH gene in the genome of Bacillus licheniformis DW2 is amplified by yqdH-F2 and yqdH-R2, the genome of Bacillus subtilis 168 is used as a template, and P43-F1 and P43-R are used as primers to obtain a P43 promoter through amplification. P43-F1 and yqdH-R2 are used as primers, and the two fragments of P43 and yqdH are subjected to SOE-PCR to obtain a fusion fragment P43-yqdH. Plasmid pHY-F542W or pHY-kivD is used as a template, and amp-T5-F and amp-T5-R are used as primers to carry out whole plasmid PC R amplification, so as to obtain linearized pHY-F542W and pHY-kivD. And (3) after the amplification products are subjected to electrophoresis detection, purifying and recovering the PCR products by using a gel recovery kit. The yqdH fragment was inserted into the expression vectors pHY-F542W and pHY-kivD by Cloneexpress II one-step cloning kit, respectively, and the success of the construction of the recombinant co-expression plasmids pHY-F542W-yqdH and pHY-kivD-yqdH was confirmed by colony PCR and DNA sequencing.
yqdH-F2:TCTAAAGGAGGAAGGATCAATGGATAATTTTACATATTG
yqdH-R2:GTAAACTTGGTCTGACAGTTATAAAGAAGCCTTCAAAAT
P43-F1:ACTTTTCGGGGAAATGTCTGATAGGTGGTATGTTTTCG
P43-R1:CAATATGTAAAATTATCCATTGATCCTTCCTCCTTTAGA
amp-T5-F:GACATTTCCCCGAAAAGTGCCAC
amp-T5-R:CTGTCAGACCAAGTTTACTCATATA。
Example 4:
construction of recombinant DW2/pHY-kivD-yqdH and DW2/pHY-F542W-yqdH Bacillus licheniformis
The constructed pHY-kivD-yqdH plasmid or the recombinant plasmid pHY-F542W-yqdH is respectively electrically transformed into the bacillus licheniformis DW 2. Transformants are selected by pHY-F and pHY-R primers for colony PCR, and gel electrophoresis verification shows that a 2800bp band appears, the successful construction of recombinant Bacillus licheniformis DW2/pHY-kivD-yqdH and DW2/pHY-F542W-yqdH is verified, DW2/pHY-kivD-yqdH is shown in figure 2, and the plasmid structure of DW2/pHY-F542W-yqdH is that kivD in DW2/pHY-kivD-yqdH is changed into a kivD mutant.
pHY-F:CAGATTTCGTGATGCTTGTC
pHY-R:GTTTATTATCCATACCCTTAC。
Example 5:
influence of molasses concentration on recombinant bacteria DW2/pHY-kivD-yqdH and DW2/pHY-F542W-yqdH in production of phenethyl alcohol by fermentation:
the cells cultured in example 4 were used as a catalyst, and the final concentration of the added cells was OD600The concentration of molasses is 0.2, 40, 60, 80, 100, 120 and 140g/L, the other culture medium components are 10g/L sodium citrate, 5g/L L-phenylalanine, 2g/L yeast extract,6.4g/L KH2PO4,5.32g/L K2HPO4,0.6g/L MgSO4·7H2O,0.005g/L MnCl2,0.003g/L FeSO4·7H2O,0.003g/L CaCl2The content of phenethyl alcohol was measured at pH6.5 and at a culture temperature of 37 ℃ for 60 hours of fermentation, and the results shown in Table 1 show that the content of phenethyl alcohol was higher at a molasses concentration of 60-100 and highest at a molasses concentration of 80. The yield of the recombinant strain DW2/pHY-F542W-yqdH phenethyl alcohol is higher than that of the control strain.
TABLE 1 influence of molasses concentration on recombinant bacteria DW2/pHY-kivD-yqdH and DW2/pHY-F542W-yqdH in the fermentative production of phenethyl alcohol
Figure GDA0003581080970000071
Figure GDA0003581080970000081
Example 6:
influence of pH during fermentation on recombinant bacteria DW2/pHY-kivD-yqdH and DW2/pHY-F542W-yqdH in the production of phenethyl alcohol by fermentation:
the cells cultured in example 4 were used as a catalyst, and the final concentration of the added cells was OD600The culture medium components are 60g/L of molasses, 10g/L of sodium citrate, 5g/L L-phenylalanine, 2g/L of yeast extract and 0.6g/L of Mg SO respectively4·7H2O,0.005g/L MnCl2,0.003g/L FeSO4·7H2O,0.003g/L CaCl2Fermenting for 60h at 37 deg.C to change KH2PO4And K2HPO4The content of phenethyl alcohol was measured in the reaction system at such concentrations that the pH was 6.5, 6.8, 7.0 and 7.5, respectively, and as a result, as shown in Table 2, the content of phenethyl alcohol was the highest at pH 7.0. The DW2/pHY-F542W-yqdH yield is at least 12 percent higher than the phenethyl alcohol yield of the control bacteria.
TABLE 2 influence of pH during fermentation on recombinant bacteria DW2/pHY-kivD-yqdH and DW2/pHY-F542W-yqdH in the fermentative production of phenethyl alcohol:
Figure GDA0003581080970000082
example 7:
the influence of the inoculation amount on the recombinant bacteria DW2/pHY-kivD-yqdH and DW2/pHY-F542W-yqdH in the production of phenethyl alcohol by fermentation:
the cells obtained by culturing in example 4 were used as a catalyst, and the medium components were 80g/L molasses, 10g/L sodium citrate, 5g/L L-phenylalanine, 2g/L yeast extract, and 14.14g/L KH 2PO4,5.17g/L K2HPO4,0.6g/L MgS O4·7H2O,0.005g/L MnCl2,0.003g/L FeSO4·7H2O,0.003g/L CaCl2pH7.0, final concentrations of the added cells of 0.2, 1.0, 2.0 and 5.0, fermentation for 60h, and measurement of phenethyl alcohol content at 37 deg.C, the results are shown in Table 3 when the initial final concentration of the cells is OD600The highest phenethyl alcohol content is obtained when the content is 0.2-1.0. The DW2/pHY-F542W-yqdH yield is at least improved by 9 percent compared with the phenethyl alcohol yield of the control bacteria.
Table 3 Effect of inoculum size on recombinant bacteria DW2/pHY-kivD-yqdH and DW2/pHY-F542W-yqdH in the fermentative production of phenethyl alcohol:
Figure GDA0003581080970000091
example 8:
influence of substrate concentration on recombinant bacteria DW2/pHY-kivD-yqdH and DW2/pHY-F542W-yqdH in production of phenethyl alcohol by fermentation:
the cells obtained by culturing in example 4 were used as a catalyst, and the medium components were 80g/L molasses, 10g/L sodium citrate, 2g/L yeast extract, and 14.14g/L KH2PO4,5.17g/L K2HPO4,0.6g/L MgSO4·7H2O,0.005g/L MnCl2,0.003g/L FeSO4·7H2O,0.003g/L CaCl2pH7.0, final concentration of added cells is 0.2, 5, 6, 8 and 10g/L of L-phenylalanine are respectively added into the reaction system, fermentation is carried out for 60 hours, the reaction temperature is 37 ℃, and the yield of the phenethyl alcohol generated by adding 5, 6, 8 and 10g/L of L-phenylalanine is detected and is shown in Table 4, and the yield of the phenethyl alcohol is increased along with the increase of the concentration of the L-phenylalanine. When 10g/L L-phenylalanine is added, the yield of phenethyl alcohol of the DW2/pHY-F542W-yqdH strain is the highest and reaches 5.15 g/L. Compared with the control strain, the strain is improved by 16 percent. The highest L-phenylalanine conversion rate of the DW2/pHY-F542W-yqdH strain can reach 94.32 percent.
TABLE 4 influence of substrate concentration on the fermentation production of phenethyl alcohol by recombinant bacteria DW2/pHY-kivD-yqdH and DW 2/pHY-F542W-yqdH:
Figure GDA0003581080970000092
Figure GDA0003581080970000101
although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
Sequence listing
<110> university of Hubei
<120> whole-cell catalyst containing phenylpyruvate decarboxylase mutant and application thereof in production of phenethyl alcohol
<160> 22
<170> SIPOSequenceListing 1.0
<210> 1
<211> 548
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 1
Met Tyr Thr Val Gly Asp Tyr Leu Leu Asp Arg Leu His Glu Leu Gly
1 5 10 15
Ile Glu Glu Ile Phe Gly Val Pro Gly Asp Tyr Asn Leu Gln Phe Leu
20 25 30
Asp Gln Ile Ile Ser Arg Lys Asp Met Lys Trp Val Gly Asn Ala Asn
35 40 45
Glu Leu Asn Ala Ser Tyr Met Ala Asp Gly Tyr Ala Arg Thr Lys Lys
50 55 60
Ala Ala Ala Phe Leu Thr Thr Phe Gly Val Gly Glu Leu Ser Ala Val
65 70 75 80
Asn Gly Leu Ala Gly Ser Tyr Ala Glu Asn Leu Pro Val Val Glu Ile
85 90 95
Val Gly Ser Pro Thr Ser Lys Val Gln Asn Glu Gly Lys Phe Val His
100 105 110
His Thr Leu Ala Asp Gly Asp Phe Lys His Phe Met Lys Met His Glu
115 120 125
Pro Val Thr Ala Ala Arg Thr Leu Leu Thr Ala Glu Asn Ala Thr Val
130 135 140
Glu Ile Asp Arg Val Leu Ser Ala Leu Leu Lys Glu Arg Lys Pro Val
145 150 155 160
Tyr Ile Asn Leu Pro Val Asp Val Ala Ala Ala Lys Ala Glu Lys Pro
165 170 175
Ser Leu Pro Leu Lys Lys Glu Asn Ser Thr Ser Asn Thr Ser Asp Gln
180 185 190
Glu Ile Leu Asn Lys Ile Gln Glu Ser Leu Lys Asn Ala Lys Lys Pro
195 200 205
Ile Val Ile Thr Gly His Glu Ile Ile Ser Phe Gly Leu Glu Lys Thr
210 215 220
Val Ser Gln Phe Ile Ser Lys Thr Lys Leu Pro Ile Thr Thr Leu Asn
225 230 235 240
Phe Gly Lys Ser Ser Val Asp Glu Ala Leu Pro Ser Phe Leu Gly Ile
245 250 255
Tyr Asn Gly Lys Leu Ser Glu Pro Asn Leu Lys Glu Phe Val Glu Ser
260 265 270
Ala Asp Phe Ile Leu Met Leu Gly Val Lys Leu Thr Asp Ser Ser Thr
275 280 285
Gly Ala Phe Thr His His Leu Asn Glu Asn Lys Met Ile Ser Leu Asn
290 295 300
Ile Asp Glu Gly Lys Ile Phe Asn Glu Ser Ile Gln Asn Phe Asp Phe
305 310 315 320
Glu Ser Leu Ile Ser Ser Leu Leu Asp Leu Ser Glu Ile Glu Tyr Lys
325 330 335
Gly Lys Tyr Ile Asp Lys Lys Gln Glu Asp Phe Val Pro Ser Asn Ala
340 345 350
Leu Leu Ser Gln Asp Arg Leu Trp Gln Ala Val Glu Asn Leu Thr Gln
355 360 365
Ser Asn Glu Thr Ile Val Ala Glu Gln Gly Thr Ser Phe Phe Gly Ala
370 375 380
Ser Ser Ile Phe Leu Lys Pro Lys Ser His Phe Ile Gly Gln Pro Leu
385 390 395 400
Trp Gly Ser Ile Gly Tyr Thr Phe Pro Ala Ala Leu Gly Ser Gln Ile
405 410 415
Ala Asp Lys Glu Ser Arg His Leu Leu Phe Ile Gly Asp Gly Ser Leu
420 425 430
Gln Leu Thr Val Gln Glu Leu Gly Leu Ala Ile Arg Glu Lys Ile Asn
435 440 445
Pro Ile Cys Phe Ile Ile Asn Asn Asp Gly Tyr Thr Val Glu Arg Glu
450 455 460
Ile His Gly Pro Asn Gln Ser Tyr Asn Asp Ile Pro Met Trp Asn Tyr
465 470 475 480
Ser Lys Leu Pro Glu Ser Phe Gly Ala Thr Glu Glu Arg Val Val Ser
485 490 495
Lys Ile Val Arg Thr Glu Asn Glu Phe Val Ser Val Met Lys Glu Ala
500 505 510
Gln Ala Asp Pro Asn Arg Met Tyr Trp Ile Glu Leu Ile Leu Ala Lys
515 520 525
Glu Asp Ala Pro Lys Val Leu Lys Lys Met Gly Lys Leu Trp Ala Glu
530 535 540
Gln Asn Lys Ser
545
<210> 2
<211> 387
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 2
Met Asp Asn Phe Thr Tyr Trp Asn Pro Thr Lys Leu Ile Phe Gly Arg
1 5 10 15
Gly Glu Val Glu Lys Leu Ala Glu Glu Val Lys His Tyr Gly Arg Asn
20 25 30
Val Leu Leu Val Tyr Gly Gly Gly Ser Ile Lys Arg Asn Gly Leu Tyr
35 40 45
Asp Gln Val Ile Ser Ile Leu Glu Lys Ala Gly Ala Thr Val His Glu
50 55 60
Leu Pro Gly Val Glu Pro Asn Pro Arg Val Ala Thr Val Asn Lys Gly
65 70 75 80
Val Ala Ile Cys Lys Glu Asn Asp Ile Asn Phe Leu Leu Ala Val Gly
85 90 95
Gly Gly Ser Val Ile Asp Cys Thr Lys Ala Ile Ala Ala Gly Ala Lys
100 105 110
Tyr Asp Gly Asp Ala Trp Asp Ile Val Thr Lys Lys His Ile Pro Ala
115 120 125
Asp Ala Leu Pro Phe Gly Thr Val Leu Thr Leu Ala Ala Thr Gly Ser
130 135 140
Glu Met Asn Ser Gly Ser Val Ile Thr Asn Trp Glu Thr Asn Glu Lys
145 150 155 160
Tyr Gly Trp Gly Ser Pro Leu Val Phe Pro Lys Phe Ser Ile Leu Asp
165 170 175
Pro Val Asn Thr Phe Thr Val Pro Lys Asp His Thr Ile Tyr Gly Ile
180 185 190
Val Asp Met Met Ser His Val Phe Glu Gln Tyr Phe His His Thr Glu
195 200 205
Asn Thr Pro Tyr Gln Asp Arg Met Cys Glu Ser Leu Leu Lys Thr Val
210 215 220
Ile Glu Thr Ala Ser Lys Leu Ile Glu Asp Leu Glu Asn Tyr Glu Leu
225 230 235 240
Arg Glu Thr Ile Leu Tyr Thr Gly Thr Ile Ala Leu Asn Gly Met Leu
245 250 255
Ser Met Gly Ala Arg Gly Asp Trp Ala Thr His Asn Ile Glu His Ala
260 265 270
Val Ser Ala Val Tyr Asp Ile Pro His Ala Gly Gly Leu Ala Ile Leu
275 280 285
Phe Pro Asn Trp Met Lys His Thr Leu Ser Glu Asn Val Gly Arg Phe
290 295 300
Lys Gln Leu Ala Val Arg Val Phe Asp Val Asp Glu Thr Gly Lys Thr
305 310 315 320
Asp Arg Glu Val Ala Leu Val Gly Ile Glu Lys Leu Ser Glu Phe Trp
325 330 335
Thr Ser Leu Gly Ala Pro Asn Arg Leu Ala Asp Tyr Asp Ile Thr Asp
340 345 350
Glu Lys Leu Asp Leu Ile Ala Asp Lys Ala Met Ala Asn Gly Glu Phe
355 360 365
Gly Arg Phe Lys Thr Leu Asn Lys Asp Asp Val Leu Ser Ile Leu Lys
370 375 380
Ala Ser Leu
385
<210> 3
<211> 38
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
tttttataac aggaattctg ataggtggta tgttttcg 38
<210> 4
<211> 39
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
taatctccta ctgtatacat tgatccttcc tcctttaga 39
<210> 5
<211> 38
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
ctaaaggagg aaggatcaat gtatacagta ggagatta 38
<210> 6
<211> 38
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
tccgtcctct ctgctctttt atgatttatt ttgttcag 38
<210> 7
<211> 40
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
ctgaacaaaa taaatcataa aagagcagag aggacggatt 40
<210> 8
<211> 40
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
aagcttctag aagcttctag cgcaataatg ccgtcgcact 40
<210> 9
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 9
gaattcctgt tataaaaaaa ggatc 25
<210> 10
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 10
tctagaagct tgggcaaagc gtttt 25
<210> 11
<211> 39
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 11
gatttatttt gttcagccca tagtttgccc atttttttc 39
<210> 12
<211> 39
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 12
gaaaaaaatg ggcaaactat gggctgaaca aaataaatc 39
<210> 13
<211> 28
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 13
cgggatccat ggataatttt acatattg 28
<210> 14
<211> 30
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 14
ccgctcgagt tataaagaag ccttcaaaat 30
<210> 15
<211> 39
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 15
tctaaaggag gaaggatcaa tggataattt tacatattg 39
<210> 16
<211> 39
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 16
gtaaacttgg tctgacagtt ataaagaagc cttcaaaat 39
<210> 17
<211> 38
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 17
acttttcggg gaaatgtctg ataggtggta tgttttcg 38
<210> 18
<211> 39
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 18
caatatgtaa aattatccat tgatccttcc tcctttaga 39
<210> 19
<211> 23
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 19
gacatttccc cgaaaagtgc cac 23
<210> 20
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 20
ctgtcagacc aagtttactc atata 25
<210> 21
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 21
cagatttcgt gatgcttgtc 20
<210> 22
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 22
gtttattatc cataccctta c 21

Claims (6)

1. A whole-cell catalyst containing a phenylpyruvate decarboxylase mutant is a bacillus licheniformis co-expressing the phenylpyruvate decarboxylase mutant F542W and alcohol dehydrogenase, and the amino acid sequence of the mutant F542W is shown in SEQ ID NO. 1.
2. The whole-cell catalyst of claim 1, wherein the Bacillus licheniformis is Bacillus licheniformisBacillus licheniformis DW2,CCTCC NO:M2011344。
3. The whole-cell catalyst according to claim 1, wherein the alcohol dehydrogenase is derived fromBacillus licheniformis DW2, the amino acid sequence of alcohol dehydrogenase is shown in SEQ ID NO. 2.
4. The whole-cell catalyst according to claim 1, which is obtained by converting a gene encoding mutant F542W and a gene derived from the sameBacillus licheniformis DW2 alcohol dehydrogenase encoding geneyqdHConstructed into plasmid pHY300PLK and transformed into Bacillus licheniformis DW 2.
5. Use of the whole-cell catalyst of claim 1 for the production of phenethyl alcohol.
6. Use of the whole-cell catalyst of claim 1 for the production of a phenethyl alcohol derivative.
CN201910705699.4A 2019-08-01 2019-08-01 Whole-cell catalyst containing phenylpyruvate decarboxylase mutant and application of whole-cell catalyst in production of phenethyl alcohol Active CN110438055B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910705699.4A CN110438055B (en) 2019-08-01 2019-08-01 Whole-cell catalyst containing phenylpyruvate decarboxylase mutant and application of whole-cell catalyst in production of phenethyl alcohol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910705699.4A CN110438055B (en) 2019-08-01 2019-08-01 Whole-cell catalyst containing phenylpyruvate decarboxylase mutant and application of whole-cell catalyst in production of phenethyl alcohol

Publications (2)

Publication Number Publication Date
CN110438055A CN110438055A (en) 2019-11-12
CN110438055B true CN110438055B (en) 2022-05-27

Family

ID=68432686

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910705699.4A Active CN110438055B (en) 2019-08-01 2019-08-01 Whole-cell catalyst containing phenylpyruvate decarboxylase mutant and application of whole-cell catalyst in production of phenethyl alcohol

Country Status (1)

Country Link
CN (1) CN110438055B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114891820B (en) * 2022-05-28 2023-05-23 湖北大学 Bacillus licheniformis for efficiently synthesizing hydroxytyrosol, construction method and application

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102851253A (en) * 2012-08-03 2013-01-02 江南大学 Escherichia coli engineering strain having high phenethyl alcohol yield and application thereof
CN104195125A (en) * 2014-07-01 2014-12-10 中国科学院广州能源研究所 Alpha-ketoacid decarboxylase KIVD-LL, and encoding gene and application thereof
CN106566794A (en) * 2015-10-09 2017-04-19 中国科学院微生物研究所 A genetically engineered bacterium producing 2-phenylethanol and an applying method thereof
CN106957878A (en) * 2017-04-19 2017-07-18 波顿(上海)生物技术有限公司 A kind of method that living things catalysis produces 2 benzyl carbinols

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2678261A1 (en) * 2007-02-09 2008-08-14 The Regents Of The University Of California Biofuel production by recombinant microorganisms
US20150259710A1 (en) * 2011-07-28 2015-09-17 Gevo, Inc. Decarboxylase proteins with high keto-isovalerate decarboxylase activity
US10829756B2 (en) * 2015-08-28 2020-11-10 The Regents Of The University Of California Discovery of enzymes from the alpha-keto acid decarboxylase family
US10941379B2 (en) * 2016-05-09 2021-03-09 Massachusetts Institute Of Technology Microbial system for biosynthesis of natural and engineered products coupled to in situ extraction in supercritical CO2

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102851253A (en) * 2012-08-03 2013-01-02 江南大学 Escherichia coli engineering strain having high phenethyl alcohol yield and application thereof
CN104195125A (en) * 2014-07-01 2014-12-10 中国科学院广州能源研究所 Alpha-ketoacid decarboxylase KIVD-LL, and encoding gene and application thereof
CN106566794A (en) * 2015-10-09 2017-04-19 中国科学院微生物研究所 A genetically engineered bacterium producing 2-phenylethanol and an applying method thereof
CN106957878A (en) * 2017-04-19 2017-07-18 波顿(上海)生物技术有限公司 A kind of method that living things catalysis produces 2 benzyl carbinols

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Protein engineering of α -ketoisovalerate decarboxylase for improved isobutanol production in Synechocystis PCC 6803;Rui Miao,等;《Metabolic Engineering》;20181231;第42-48页 *

Also Published As

Publication number Publication date
CN110438055A (en) 2019-11-12

Similar Documents

Publication Publication Date Title
CN108823179B (en) Transaminase derived from actinomycetes, mutant, recombinant bacterium and application
CN111676203B (en) Leucine dehydrogenase mutant and application thereof
CN108467860B (en) Method for high yield of gamma-aminobutyric acid
CN110938616B (en) Mutant of nitrile hydratase derived from hot spring thermokalite bacillus
CN106754775B (en) A kind of carbonyl reduction enzyme mutant and its gene and application
CN106566823B (en) Cloning and application of glutamate decarboxylase gene
CN111690624A (en) Method for synthesizing 2-O-alpha-D-glycerol glucoside by using microorganisms
CN114525268B (en) Glutamate decarboxylase mutant with improved pH tolerance and application of glutamate decarboxylase mutant in synthesis of gamma-aminobutyric acid
CN110438055B (en) Whole-cell catalyst containing phenylpyruvate decarboxylase mutant and application of whole-cell catalyst in production of phenethyl alcohol
CN112831488B (en) Glutamic acid decarboxylase and gamma-aminobutyric acid high-yield strain
CN110331173B (en) Application of phenylpyruvic acid decarboxylase mutant M538A in production of phenethyl alcohol through biological fermentation
CN107881159B (en) Method for improving soluble heterologous expression of D-amino acid oxidase
CN111808829B (en) Gamma-glutamyl methylamine synthetase mutant and application thereof
CN107312766B (en) Pyruvate decarboxylase mutant with improved enzyme activity
CN110592035B (en) Carbonyl reductase mutant, recombinant expression vector and application of carbonyl reductase mutant in production of chiral alcohol
CN111454918A (en) Enol reductase mutant and application thereof in preparation of (R) -citronellal
CN108004225B (en) Mutant of phenylalanine aminomutase from Pantoea agglomerans
CN115058408B (en) Metagenome-derived high-specific-activity acid-resistant D-psicose 3-epimerase and encoding gene and application thereof
CN108048439B (en) Preparation method and application of mutant trehalose synthase
CN114317510B (en) Maleic acid cis-trans isomerase mutant
CN110846288B (en) Glutathione bifunctional enzyme mutant and application thereof
CN110438097B (en) L-isoleucine hydroxylase mutant with improved heat stability and enzyme activity
CN110295204B (en) Application of phenylpyruvic acid decarboxylase mutant F542W in production of phenethyl alcohol through biological fermentation
CN113355366A (en) Method for preparing 2-phenethyl alcohol by multi-enzyme cascade
CN112442474B (en) Preparation method of (-) gamma-lactam

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant